Loading organizations...
Alma Health is a digital healthcare platform that provides virtual doctor consultations, automatic prescription renewals, and expedited medication delivery for individuals managing chronic conditions, and is based in Abu Dhabi, United Arab Emirates. The company operates as a centralized digital clinic and pharmacy across three countries in the Middle East and North Africa region, specifically targeting patients with diabetes, hypertension, and cholesterol. The healthtech startup has raised a total of $10 million in Series A equity funding to support its consumer and enterprise telemedicine services across the region. Alma Health integrates its digital pharmacy operations with major health insurance networks and is backed by venture capital investors including Knuru Capital, e& capital, Shorooq Partners, and Hambro Perks Oryx Fund. The healthcare enterprise was officially founded in 2021 by founders Khaldoon Bushnaq and Tariq Seksek.
Alma Health has raised $10.0M across 1 funding round.
Alma Health has raised $10.0M in total across 1 funding round.
Alma Health has raised $10.0M in total across 1 funding round.
Alma Health's investors include Hambro Perks.
Alma Health has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in July 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 1, 2023 | $10M Series A | — | Hambro Perks | Announced |
Alma Health is a digital healthcare company focused on transforming chronic disease management through an end-to-end digital platform. It serves patients with chronic conditions by providing virtual doctor consultations, automatic prescription renewals, home delivery of medications, and ongoing care support, creating a seamless healthcare experience from diagnosis to treatment and follow-up[1][4][5][6]. The platform is designed to improve health outcomes by leveraging technology for personalized, continuous care, primarily operating in the UAE and Saudi Arabia[4][5].
Founded in May 2021, Alma Health was launched in Abu Dhabi, driven by co-founder Khaldoon Bushnaq’s vision to innovate healthcare for chronic illness patients in a region with a high prevalence of such conditions[4][5]. The company emerged from the recognition that traditional healthcare systems had not evolved significantly for chronic care, prompting Alma Health to build a digitally native healthcare experience that integrates consultations, medication management, and community support in one platform[1][5]. Early traction was supported by its acceptance into Abu Dhabi’s Hub71 technology hub, which provided a supportive ecosystem for innovation[5].
Alma Health rides the global trend toward digital health transformation, particularly accelerated by the COVID-19 pandemic’s push for telemedicine and remote care. The timing is critical as chronic diseases represent a growing global burden, and healthcare systems seek scalable, patient-centric solutions. Market forces such as increased smartphone penetration, regulatory openness to digital health, and rising patient demand for convenience favor Alma Health’s model. By integrating virtual care, medication management, and data analytics, Alma Health influences the broader ecosystem by setting a standard for comprehensive chronic care management in emerging markets[4][5].
Looking ahead, Alma Health is positioned to expand its digital chronic care ecosystem beyond the GCC, potentially incorporating advanced remote monitoring and AI-driven personalized treatments. Trends shaping its journey include the increasing adoption of telehealth, growing chronic disease prevalence, and healthcare digitization mandates worldwide. Alma Health’s influence may evolve from a regional innovator to a global leader in chronic disease management platforms, driving improved patient outcomes and healthcare efficiencies through technology[5]. This aligns with its mission to make chronic care more accessible, personalized, and effective, fulfilling a critical gap in modern healthcare delivery.
